• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Healthcare, Regulatory and Reimbursement Landscape - China - Product Image

Healthcare, Regulatory and Reimbursement Landscape - China

  • Published: February 2012
  • Region: China
  • 181 pages
  • GlobalData

Healthcare, Regulatory and Reimbursement Landscape - China

Summary

GlobalData, Industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - China”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of China. The report identifies the key trends in the Chinese healthcare market, as well as insights on the demographics, the regulatory and reimbursement landscapes and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

China is the most populated country in the world. In 2010, the population of China was approximately 1.3 billion – approximately one-fifth of the global population. Population growth in China has been increasing with a slow growth rate due to the strict enforcement of the country’s one-child policy. The decline in the READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Report Guidance
3 Overview of the Pharmaceutical and Medical Devices Market
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Supply Channels
3.1.3 Market Segments
3.1.4 Major Disease Areas
3.1.5 Major Players
3.2 Medical Device Market
3.2.1 Market Overview
3.2.2 Overview of Top Five Segments
3.2.3 Major Players
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Reimbursement Process
4.1.2 Overview of Insurance Providers
4.1.3 Patient Share in Healthcare Spending
4.1.4 Drug Price Trends
4.1.5 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 New Drug Approval Process
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of Current Political Environment
5.1.3 Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserve
5.3.7 Trade Balance
5.3.8 Government Structural Balance
5.3.9 Government Net Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Spending in Pharmaceutical R&D
5.6.4 Share of Public and Private Sector
5.7 Trade Associations and Trade Fairs
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Methodology
7.2.1 Coverage
7.2.2 Secondary Research
7.2.3 Forecasting
7.2.4 Primary Research
7.2.5 Expert Panel Validation
7.3 Contact Us
7.4 Disclaimer
7.5 Bibliography

1.1 List of Tables
Table 1: Pharmaceutical Industry ($bn), China, 2005 - 2010
Table 2: Pharmaceutical Industry ($bn), China, Forecast, 2011 - 2020
Table 3: Branded and Generic Drugs, China, Market Share by Type of Hospital (%), 2008
Table 4: Branded and Generic Drugs, China, Market Share by Disease Area (%), 2008
Table 5: Average Price Ratio of Branded and Generic Drugs, China, 2008
Table 6: Major OTC Pharmaceuticals, China, 2010
Table 7: OTC Pharmaceutical Market ($bn), China, 2005 - 2010
Table 8: Share of the Anti-infective Drugs by Class, EDL, China, 2010
Table 9: Major Pharmaceutical Companies, China, Revenue ($bn), 2010
Table 10: Major Products, Harbin Pharmaceuticals Group, 2011
Table 11: Major Products, Tasly Group Co., Ltd., 2011
Table 12: Major Products, Yangtze River Pharmaceutical Group, 2011
Table 13: Major Products, Xiuzheng Pharmaceutical Group, 2011
Table 14: Major Products, North China Pharmaceutical Group, 2011
Table 15: Medical Device Market ($bn), China, 2005 - 2010
Table 16: Medical Device Market ($bn), China, Forecast, 2011 - 2020
Table 17: Medical Device Market, China, Segment Share (%), 2010
Table 18: Ophthalmic Devices Market ($bn), China, 2005 - 2010
Table 19: Sales Trends for Major Players-, Ophthalmic Devices, China, 2010
Table 20: In Vitro Diagnostics Market ($bn), China, 2005 - 2010
Table 21: Sales Trends for Major Players-, in Vitro Diagnostics, China, 2010
Table 22: Diagnostic Imaging Market ($bn), China, 2005 - 2010
Table 23: Sales Trends for Major Players-, Diagnostic Imaging, China, 2010
Table 24: Cardiovascular Devices Market ($bn), China, 2005 - 2010
Table 25: Sales Trends for Major Players-, Cardiovascular Devices, China, 2010
Table 26: Diabetes Care Devices Market ($bn), China, 2005 - 2010
Table 27: Sales Trends for Major Players-, Diabetes Care Devices, China, 2010
Table 28: Major Medical Device Companies, China, Revenue ($m), 2010
Table 29: Major Products, Siemens, Global, Revenue ($m), 2010
Table 30: Late Stage Pipeline, GE Healthcare, 2011
Table 31: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2010
Table 32: Major Products, Medtronic, Global, Revenue ($m), 2011
Table 33: Major Products, Roche, Global, Revenue ($m), 2010
Table 34: Late Stage Pipeline, F. Hoffmann-La Roche Ltd., 2010
Table 35: Out-of-Pocket Healthcare Expenditure, China, Share (%), 2005 - 2010
Table 36: Change in Average Price of Drugs (%), China, 2005 - 2009
Table 37: GDP ($bn), China, 2005 - 2010
Table 38: GDP ($bn), China, 2011 - 2020
Table 39: GDP, China, Annual Growth (%), 2005 - 2010
Table 40: GDP, China, Annual Growth (%), Forecast, 2011 - 2020
Table 41: GNI Per Capita ($), China, 2005 - 2010
Table 42: GNI Per Capita ($), China, Forecast, 2011 - 2020
Table 43: Average Consumer Price Index, China, 2005 - 2010
Table 44: Average Consumer Price, China, Annual Change (%), 2005 - 2010
Table 45: Average Consumer Price Index, China, Annual Change (%), Forecast, 2011 - 2020
Table 46: Currency Exchange Rate (Yuan/$), China, 2005 - 2010
Table 47: Foreign Direct Investment ($bn), China, 2005 - 2010
Table 48: Foreign Exchange Reserves ($bn), China, 2005 - 2010
Table 49: Trade Balance ($bn), China, 2005 - 2010
Table 50: Total Imports Value ($bn), China, 2005 - 2010
Table 51: Total Exports Value ($bn), China, 2005 - 2010
Table 52: General Government Structural Balance ($bn), China, 2005 - 2010
Table 53: Government Net Debt ($bn), China, 2005 - 2010
Table 54: Major Industries, China, Revenue ($bn), 2009
Table 55: Population (m), China, 2005 - 2010
Table 56: Population (m), China, Forecast, 2011 - 2020
Table 57: Urban and Rural Population, China, Share (%), 2005 - 2010
Table 58: Urban and Rural Population, China, Share (%), Forecast, 2011 - 2020
Table 59: Age Groups, Population Distribution (%), Country, 2005 - 2010
Table 60: Age Groups, Population Distribution (%), China, Forecast, 2011 - 2020
Table 61: Births (Per 1,000 Population), China, 2005 - 2010
Table 62: Births (Per 1,000 Population), China, Forecast, 2011 - 2020
Table 63: Mortality (Per 1,000 People), China, 2005 - 2010
Table 64: Mortality (Per 1,000 Population), China, Forecast, 2011 - 2020
Table 65: Major Causes of Mortality (‘000s), China, 2008
Table 66: Maternal Mortality Rate (Per 100,000 Live Births), China, 2005 - 2010
Table 67: Maternal Mortality Rate (Per 100,000 Live Births), China, Forecast, 2011 - 2020
Table 68: Children <5 Years Age, China, Mortality Rate (Per 1,000 Live Births), 2005 - 2010
Table 69: Children <5 Years Age, China, Mortality Rate (Per 1,000 Live Births), Forecast, 2011 - 2020
Table 70: Immunization Rate (%), China, 2000 - 2009
Table 71: Major Causes of Male Mortality (‘000s), China, 2008
Table 72: Major Causes of Female Mortality (‘000s), China, 2008
Table 73: Gender Ratio (M/F), China, 2005 - 2010
Table 74: Gender Ratio (M/F), China, Forecast, 2011 - 2020
Table 75: Life Expectancy at Birth (Years), China, 2005 - 2010
Table 76: Life Expectancy at Birth (Years), China, Forecast, 2011 - 2020
Table 77: Levels of Education, China, Students Share (%), 2009
Table 78: Literacy Rate (%), China, 2005 - 2010
Table 79: Employees, China, Urban-Rural (m), 2005 - 2010
Table 80: Unemployment Rate (%), China, 2005 - 2010
Table 81: Major Diseases, China, Inpatients (%), City Hospitals, 2009
Table 82: Major Diseases, China, Inpatients (%), County Hospitals, 2009
Table 83: Major Diseases, China, DALYs (Per 100,000 Population), 2004
Table 84: Public and Private Hospitals, China, 2010 - 2011
Table 85: Hospitals by Standard of Care, China, Share (%), 2011
Table 86: Hospital Beds by Type of Services, China, Share (%), 2009
Table 87: Beds (Per 1,000 Population), China, 2005 - 2010
Table 88: Beds (Per 1,000 People), China, 2011 - 2020
Table 89: Hospital Beds (m), China, 2005 - 2010
Table 90: Hospital Beds (m), China, Forecast, 2011 - 2020
Table 91: Physicians (Per 1,000 Population), China, 2005 - 2010
Table 92: Air Quality (%), Cities, China, 2006 and 2009
Table 93: Major Air Pollutants (1,000 Tons), China, 2006 - 2009
Table 94: TSP Levels (µg/m3) in Five Cities, China, 1998 and 2004
Table 95: Water Quality (%), China, 2006 and 2009
Table 96: Waste Water (bn Tons), COD and Ammonia (m Tons), China, Discharge, 2006 - 2009
Table 97: Population on Improved Drinking Water and Sanitation Facilities (%), China, 1990 - 2008
Table 98: Healthcare Personnel (m), China, 2009
Table 99: Healthcare Personnel (Per 100,000 Population), China, 2005 - 2010
Table 100: Healthcare Expenditure ($bn), China, 2005 - 2010
Table 101: Healthcare Expenditure (% of GDP), China, 2005 - 2010
Table 102: Healthcare Expenditure (% of GDP), China, Forecast, 2011 - 2020
Table 103: Healthcare Expenditure, China, Pharmaceuticals Share (%), 2008
Table 104: Pharmaceutical R&D Expenditure ($bn), China, 2005 - 2010
Table 105: R&D Expenditure, China, Healthcare Share (%), 2009
Table 106: Healthcare Expenditure, China, Share of Major Components (%), 2008
Table 107: Healthcare Expenditure ($bn), China, 2005 - 2010
Table 108: Major Healthcare Trade Fairs, China

1.2 List of Figures
Figure 1: Pharmaceutical Industry ($bn), China, 2005 - 2010
Figure 2: Pharmaceutical Industry ($bn), China, Forecast, 2011 - 2020
Figure 3: Branded and Generic Drugs, China, Market Share by Type of Hospital (%), 2008
Figure 4: Branded and Generic Drugs, China, Market Share by Disease Area (%), 2008
Figure 5: OTC Pharmaceutical Market ($bn), China, 2005 - 2010
Figure 6: Share of Anti-infective Drugs by Class, EDL, China, 2010
Figure 7: Major Pharmaceutical Companies, China, Revenue ($bn), 2010
Figure 8: Medical Device Market ($bn), China, 2005 - 2010
Figure 9: Medical Device Market ($bn), China, Forecast, 2011 - 2020
Figure 10: Medical Device Market, China, Segment Share (%), 2010
Figure 11: Ophthalmic Devices Market ($bn), China, 2005 - 2010
Figure 12: Sales Trends for Major Players-, Ophthalmic Devices, China, 2005 - 2010
Figure 13: In Vitro Diagnostics Market ($bn), China, 2005 - 2010
Figure 14: Sales Trends for Major Players-, in Vitro Diagnostics, China, 2005 - 2010
Figure 15: Diagnostic Imaging Market ($bn), China, 2005 - 2010
Figure 16: Sales Trends for Major Players-, Diagnostic Imaging, China, 2005 - 2010
Figure 17: Cardiovascular Devices Market ($bn), China, 2005 - 2010
Figure 18: Sales Trends for Major Players-, Cardiovascular Devices, China, 2005 - 2010
Figure 19: Diabetes Care Devices Market ($bn), China, 2005 - 2010
Figure 20: Sales Trends for Major Players-, Diabetes Care Devices, China, 2005 - 2010
Figure 21: Major Medical Device Companies, China, Revenue ($m), 2010
Figure 22: Drivers and Barriers, Healthcare Market, China, 2011
Figure 23: Access, Reimbursement and Regulatory Environment, China
Figure 24: Pricing and Reimbursement Process, China
Figure 25: Process to Set Higher Price than Ceiling Price, China
Figure 26: Out-of-Pocket Healthcare Expenditure, China, Share (%), 2005 - 2010
Figure 27: Change in Average Price of Drugs (%), China, 2005 - 2009
Figure 28: SFDA Organizational Chart, China
Figure 29: New Drug Approval Process, China
Figure 30: New Device Approval Process, China
Figure 31: CCC Mark Certification Process, China
Figure 32: Clinical Trial Regulation Process, China
Figure 33: GDP ($bn), China, 2005 - 2010
Figure 34: GDP ($bn), China, 2011 - 2020
Figure 35: GDP, China, Annual Growth (%), 2005 - 2010
Figure 36: GDP, China, Annual Growth (%), Forecast, 2011 - 2020
Figure 37: GNI Per Capita ($), China, 2005 - 2010
Figure 38: GNI Per Capita ($), China, Forecast, 2011 - 2020
Figure 39: Average Consumer Price Index, China, 2005 - 2010
Figure 40: Average Consumer Price, China, Annual Change (%), 2005 - 2010
Figure 41: Average Consumer Price Index, China, Annual Change (%), Forecast, 2011 - 2020
Figure 42: Currency Exchange Rate (Yuan/$), China, 2005 - 2010
Figure 43: Foreign Direct Investment ($bn), China, 2005 - 2010
Figure 44: Foreign Exchange Reserves ($bn), China, 2005 - 2010
Figure 45: Trade Balance ($bn), China, 2005 - 2010
Figure 46: Total Imports Value ($bn), China, 2005 - 2010
Figure 47: Total Exports Value ($bn), China, 2005 - 2010
Figure 48: General Government Structural Balance ($bn), China, 2005 - 2010
Figure 49: Government Net Debt ($bn), China, 2005 - 2010
Figure 50: Major Industries, China, Revenue ($bn), 2009
Figure 51: Population (m), China, 2005 - 2010
Figure 52: Population (m), China, Forecast, 2011 - 2020
Figure 53: Urban and Rural Population, China, Share (%), 2005 - 2010
Figure 54: Urban and Rural Population, China, Share (%), Forecast, 2011 - 2020
Figure 55: Age Groups, Population Distribution (%), Country, 2005 - 2010
Figure 56: Age Groups, Population Distribution (%), China, Forecast, 2011 - 2020
Figure 57: Births (Per 1,000 Population), China, 2005 - 2010
Figure 58: Births (Per 1,000 Population), China, Forecast, 2011 - 2020
Figure 59: Mortality (Per 1,000 Population), China, 2005 - 2010
Figure 60: Mortality (Per 1,000 Population), China, Forecast, 2011 - 2020
Figure 61: Major Causes of Mortality (‘000s), China, 2008
Figure 62: Maternal Mortality Rate (Per 100,000 Live Births), China, 2005 - 2010
Figure 63: Maternal Mortality Rate (Per 100,000 Live Births), China, Forecast, 2011 - 2020
Figure 64: Children <5 Years Age, China, Mortality Rate (Per 1,000 Live Births), 2005 - 2010
Figure 65: Children <5 Years Age, China, Mortality Rate (Per 1,000 Live Births), Forecast, 2011 - 2020
Figure 66: Immunization Rate (%), China, 2000 - 2009
Figure 67: Major Causes of Male Mortality (‘000s), China, 2008
Figure 68: Major Causes of Female Mortality (‘000s), China, 2008
Figure 69: Gender Ratio (M/F), China, 2005 - 2010
Figure 70: Gender Ratio (M/F), China, Forecast, 2011 - 2020
Figure 71: Life Expectancy at Birth (Years), China, 2005 - 2010
Figure 72: Life Expectancy at Birth (Years), China, Forecast, 2011 - 2020
Figure 73: Levels of Education, China, Students Share (%), 2009
Figure 74: Literacy Rate (%), China, 2005 - 2010
Figure 75: Employees, China, Urban-Rural (m), 2005 - 2010
Figure 76: Unemployment Rate (%), China, 2005 - 2010
Figure 77: Major Diseases, China, Inpatients (%), City Hospitals, 2009
Figure 78: Major Diseases, China, Inpatients (%), County Hospitals, 2009
Figure 79: Major Diseases, China, DALYs (Per 100,000 Population), 2004
Figure 80: Public and Private Hospitals, China, 2010 - 2011
Figure 81: Hospitals by Standard of Care, China, Share (%), 2011
Figure 82: Hospital Beds by Type of Services, China, Share (%), 2009
Figure 83: Beds (Per 1,000 Population), China, 2005 - 2010
Figure 84: Beds (Per 1,000 People), China, 2011 - 2020
Figure 85: Hospital Beds (m), China, 2005 - 2010
Figure 86: Hospital Beds (m), China, Forecast, 2011 - 2020
Figure 87: Physicians (Per 1,000 Population), China, 2005 - 2010
Figure 88: Air Quality (%), Cities, China, 2006 and 2009
Figure 89: Major Air Pollutants (1,000 Tons), China, 2006 - 2009
Figure 90: TSP Levels (µg/m3) in Five Cities, China, 1998 and 2004
Figure 91: Water Quality (%), China, 2006 and 2009
Figure 92: Waste Water (bn Tons), COD and Ammonia (m Tons), China, Discharge, 2006 - 2009
Figure 93: Population Using Improved Drinking Water and Sanitation Facilities (%), China, 1990 - 2008
Figure 94: Healthcare Personnel (%), China, 2009
Figure 95: Healthcare Personnel (Per 100,000 Population), China, 2005 - 2010
Figure 96: Healthcare Expenditure ($bn), China, 2005 - 2010
Figure 97: Healthcare Expenditure (% of GDP), China, 2005 - 2010
Figure 98: Healthcare Expenditure (% of GDP), China, Forecast, 2011 - 2020
Figure 99: Healthcare Expenditure, China, Pharmaceuticals Share (%), 2008
Figure 100: Pharmaceutical R&D Expenditure ($bn), China, 2005 - 2010
Figure 101: R&D Expenditure, China, Healthcare Share (%), 2009
Figure 102: Healthcare Expenditure, China, Share of Major Components (%), 2008
Figure 103: Healthcare Expenditure ($bn), China, 2005 - 2010
Figure 104: Opportunities and Challenges, Healthcare Market, China, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos